[Accessed 9 September 2017]
Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
Borna A. Nyaoke, Gaudensia N. Mutua, Rose Sajabi, Delvin Nyasani, Marianne W. Mureithi, Omu A. Anzala
Research Article | published 07 Sep 2017 PLOS ONE
The majority of volunteers in the HIV vaccine trials at our site were motivated by social benefits, suggesting that altruism can be a major contributor to participation in HIV vaccine studies. Personal benefits were a secondary motivator for the volunteers. The motivators to volunteer in HIV clinical trials were similar across ages, education level and gender. Education on what is needed (including volunteer participation) to develop an efficacious vaccine could be the key to greater volunteer motivation to participate in HIV vaccine clinical trials.